Lets not get all worked up over this without a thorough understanding and analysis of the issues. I feel one shouldn't even comment without first reading the entire IOM report on how they arrived at their analysis! Do I like it no! But as I said in earlier posts, the name is NOT set in stone and that they will revisit it in 5 years. Dr. Ronn Davis of Stanford whose son has ME/CFS, stated he feels it will take less time more like two years. Let's not delve into conjecture and speculation and conspiracies. There are patients that will never except any definition unless it has ME attached to it.
You are not going to get the ME designation. The evidence is NOT there. Charles Shepard stated this in his posting here:
http://forums.phoenixrising.me/inde...-myalgic-encephalomyelitis.35504/#post-557267
I mean how is the ME label working out for patients in the UK?
The number one fact remains that a prestigious body of researchers has validated this illness as a biomedical disease. This means the aetiology is a systematic breakdown in the functioning within the organs of the body. It is
NOT caused by a psych/social model of behavioral or social theories.
There are numerous research articles on immune dysfunction, mitchrondria celluar dsyfunction, CNS/ANS dysfunction, MRI's but MRI's can also point to other causes as well etc. but the research panel stated that there was not enough conclusive evidence or a definitive study that exactly pinpointed the cause. Although some research has suggested that inflammation of the central nervous system is involved, its role is not proven, and muscle pain is not as prominent as other features. Dr. Davis and Montoya of Stanford supports it. Bateman and Klimas supports it. The panel members reached an unanimous decision focusing on the hallmarks of this disease.
My concern is the fact of not excluding or stamping out for good the psychosomatic and psychiatric disorders as in Fuduka, CCC, ICCC. I feel this leaves the door open to an end around with the psych industry. I am also concern that pain was not included.
There are patients that state that they don't have some of these symptoms. Then, maybe they don't have ME/CFS. Every patient's description and treatment plan on PR could be considered anecdotal if it wasn't first confirmed by their doctor since there are no biomarkers for this illness.
My concern is information in the physicians toolkit. Will the P2P panel validate the IOM conclusions? Will the NIH increase research funding as mentioned in the report? Will the NIH and CDC change the toolkit and diagnostic criteria? What about the ICD codes?
For me, I am in a wait and see holding pattern. I hate to see such a raging debate taking shape, splitting the patient community before all the evidence has been gathered and the final and complete decision has been decided.
My appologies for such a lengthy post.
==========================================================================
We can gain solace by these statements from the IOM panel and other doctors reactions.
"The IOM is such a prestigious body. It's the medical arm of the National Academy of Sciences. When the IOM talks, the medical community listens," Vernon said.
With the broad acceptance of a standard clinical definition, chronic fatigue syndrome patients could expect to see more support from physicians and, importantly, more coverage by insurance companies, Teitelbaum said.
People with chronic fatigue syndrome often have to convince their doctors that they aren't suffering from depression, even though their exhaustion has not left them depressed and they continue to enjoy many pleasurable interests -- just no energy to pursue them, he explained.
"You have no idea how frustrating it is to have a real devastating illness and have no name for it, to have people thinking you're a crazy person," Teitelbaum said. "Having a definition that really defines what a person has will help them get the care and support they need."
More than 1 million Americans have chronic fatigue syndrome, the CDC says, making it more prevalent than multiple sclerosis, lupus and many forms of cancer. CFS occurs most often in people in their 40s and 50s, and occurs four times more often in women than men.
Case definitions are great tools for epidemiologists, for disease hunters to get to the bottom of what's causing a malady, but they have to evolve in order to keep up with what you're finding," Vernon said.
Seeking and receiving a diagnosis can be a frustrating process for several reasons, including skepticism of health care providers about the serious nature of [chronic fatigue syndrome] and the misconception that it is a psychogenic illness or even a figment of the patient’s imagination," the panel wrote. Less than a third of medical schools include the condition in their curricula and only 40 percent of medical textbooks contain information on it, the experts said.
The cause remains unknown but symptoms may be triggered by an infection or "immunization, anesthetics, physical trauma, exposure to environmental pollutants, chemicals and heavy metals and, rarely, blood transfusions." Clayton said mononucleosis is "a major trigger" of chronic fatigue syndrome among adolescents, but little is known about causes beyond that.
Most people with ME/CFS suffer from extreme exhaustion, made worse by even mild physical or mental effort. After a crash, known as postexertional malaise, recovery may take days or weeks, and sleep brings no relief. These symptoms are recognized as key defining characteristics of the disease, according to the new criteria. Problems with speaking, thinking and remembering, known as cognitive impairments, are also widespread among patients.
Some sufferers have good days and bad days; others are confined to bed for months or years. Many people with the disease experience severe headaches, muscle pain and sensitivity to light and noise.
Dr. Ellen Wright Clayton, a Vanderbilt University specialist on genetics and the law, who chaired the committee and said
it "issued a clarion call" for physicians to do a better job.
Most patients develop the syndrome after contracting a cold, flu or other viral illness, but other environmental or toxic exposures may act as triggers. Although no cause has been identified, people with the illness may suffer neurological, hormonal and immunological impairments.
"It's time to stop saying that this is a just figment of people's imagination. This is a real disease, with real physical manifestations that need to be identified and cared for," Committee Chair Ellen Wright Clayton, MD, JD, professor of pediatrics and director of the Center for Biomedical Ethics and Society at Vanderbilt University, Nashville, Tennessee, told Medscape Medical News.
But Davis thinks its essential to do away with chronic fatigue syndrome. “My son is sick with it, and when I tell people, they say, ‘I had that once,’ because they were tired once,” he said. “ME is a better name, but there are no real data that fit the name.” Since that time, a lot of light has been shed on chronic fatigue syndrome. Doctors in 2014 linked CFS to inflammation of the nerve cells of the brain, and some now believe people with the syndrome are fatigued because something has gone wrong with their immune response.
"When you get the flu, when you get acutely sick, your body mounts a response against whatever is making you sick. That requires a significant amount of energy, and that energy is directed toward the immune response working directly and effectively," Vernon said. "Now imagine if the inflammatory response doesn't go away, and it continually requires the input of energy to maintain that response."
Some researchers believe the problem might lie in the hypothalamus, the part of the brain that regulates a wide range of different functions in the body.
"The illness represents an energy crisis on the cellular level. If you put too much demand on your body, the circuit breaker called the hypothalamus goes into a hibernation mode," Teitelbaum contends. "It takes people out of the game before they can do themselves harm."
SOURCES: News conference with: Ellen Wright Clayton, M.D., Craig-Weaver Professor of Pediatrics and professor, law, Vanderbilt University, Nashville, Tenn.; Institutes of Medicine, news release, Feb. 10, 2015; Suzanne Vernon, Ph.D., scientific director, Solve ME/CFS Initiative; Chris Fraker, Miami
Last Updated: Feb 10, 2015